This is a preview of subscription content, log in via an institution to check access.
References
Meier G, et al. Universal Mass Vaccination with Quadrivalent Influenza Vaccine (Qiv) in the United States. 18th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research : abstr. PIN79, 18 May 2013.
Pitman RJ, et al. Cost-Effectiveness Comparison of Quadrivalent Versus Trivalent Influenza Vaccines in the United States. 18th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research : abstr. PIN62, 18 May 2013.
Rights and permissions
About this article
Cite this article
Quadrivalent flu vax tops trivalent vax in the US. PharmacoEcon Outcomes News 680, 9 (2013). https://doi.org/10.1007/s40274-013-0474-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0474-7